Standout Papers

Protective effect of high density lipoprotein associated paraoxonase. Inhibition o... 1991 2026 2002 2014 985
  1. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. (1995)
    A. D. Watson, J A Berliner et al. Journal of Clinical Investigation
  2. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. (1998)
    Michael Aviram, Mira Rosenblat et al. Journal of Clinical Investigation
  3. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. (1995)
    Brian J. Van Lenten, Susan Hama et al. Journal of Clinical Investigation
  4. Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities (2005)
    Dragomir Draganov, John F. Teiber et al. Journal of Lipid Research
  5. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. (1991)
    K Gan, Andrew Smolen et al. Drug Metabolism and Disposition
  6. The Human Serum Paraoxonase/Arylesterase Gene (PON1) Is One Member of a Multigene Family (1996)
    S.L. Primo-Parmo, Robert C. Sorenson et al. Genomics
  7. Enzymatic Metabolism of Drugs and other Foreign Compounds (1958)
    B.B. Brodie, James R. Gillette et al. Annual Review of Biochemistry

Immediate Impact

23 by Nobel laureates 18 from Science/Nature 68 standout
Sub-graph 1 of 19

Citing Papers

Enzymatic construction of highly strained carbocycles
2018 StandoutScienceNobel
Directed evolution of cytochrome c for carbon–silicon bond formation: Bringing silicon to life
2016 StandoutScienceNobel
14 intermediate papers

Works of Bert N. La Du being referenced

Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities
2005 Standout
Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH
2004
and 15 more

Author Peers

Author Last Decade Papers Cites
Bert N. La Du 6764 3032 3282 3422 125 12.4k
Mira Rosenblat 3746 1161 1383 2756 87 8.3k
Michael Aviram 6439 4241 2700 5568 386 23.5k
James R. Gillette 983 3819 1117 1338 179 14.2k
Diana M. Shih 3929 3164 1359 2107 78 9.4k
Bharti Mackness 5914 798 2140 2937 95 7.7k
Dominique Pessayre 1222 4155 847 438 245 14.2k
Takako Yokozawa 821 4770 1358 2019 404 12.5k
Jacob Vaya 1175 1683 716 1288 98 6.0k
Curtis J. Omiecinski 1063 2480 595 707 117 7.4k
Shengmin Sang 1427 3486 898 1950 238 12.1k

All Works

Loading papers...

Rankless by CCL
2026